Abstract:Objective To analyze the symptoms related to liver injuries induced by anti-tuberculosis drugs and liver injury in tuberculosis(TB)patients during treatment,and to evaluate the risk of anti-tuberculosis drugs induced liver injury(ATLI)in patients with these symptoms.Methods Relevant data in the database of"Anti-tuberculosis Drugs induced Adverse Reactions in China National Tuberculosis Control and Prevention Scheme Study"(ADACS),including information of follow-up calendars and outcome,were used to analyze the distribution of symptoms related to liver injury in 4065 new smear positive TB patients during treatment with first-line anti-tuberculosis drug and evaluate the risk of ATLI on patients with these symptoms.Results The proportion of TB patients had symptoms related to liver injury during treatment was 33.9%(1377/4065).Among whom 91.1%(1255/1377)experienced 1 to 3 symptoms,and 92.2%(1269/1377)developed symptoms in intensive phase.In patients with symptoms related to liver injury,the risk of liver injury and moderate or severe liver injury increased.The rates of liver injury in patients with fever,nausea,weakness,skin rash,abdominal discomfort,anorexia and other symptoms of ATLI were 7.4%(14/190),13.3%(130/975),10.1%(51/505),10.8%(47/434),14.5%(56/387),77.4%(41/53)and 55.6%(15/27)respectively,while the rates of moderate or severe liver injury were 6.3%(12/190),5.8%(57/975),5.0%(25/505),5.3%(23/434),7.2%(28/387),60.4%(32/53)and 48.1%(13/27)respectively.Patients with each symptom of above(except fever)had higher risk of liver injury and moderate or severe liver injury than those without the symptom.The relative risk of liver injury in patients with anorexia or other symptoms of ATLI was 13.4(95% CI:10.5-17.1)and 8.7(95% CI:5.7-13.2)respectively in comparison with patients without the symptom,and the relative risk of moderate or severe liver injury was 27.5(95% CI:21.2-35.7)and 18.2(95% CI:12.1-27.3)respectively.The relative risk of moderate or severe liver injury in patients with fever was 2.3(95% CI:1.3-4.0)compared with patients without fever.Conclusion One third of TB patients experience symptoms related with liver injury during treatment,and the symptoms mainly appear in intensive phase.Patients with nausea,weakness,skin rash,abdominal discomfort,anorexia and other symptoms of ATLI have a higher risk of liver injury.Fever may be the indicative symptom of moderate or severe liver injury,which needs to be further confirmed.

Analysis on liver damage of 781 cases tuberculosis patients

Influence Factors of Liver Injury Induced by Anti-tuberculosis Drugs

Analysis of Affecting Factors in Drug-induced Liver Injury by Antituberculous Drugs

Analysis of risk factors of drug induced liver injury caused by antituberculosis treat-ment

An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis

Analysis of the relation between symptoms related to liver injuries induced by anti-tuberculosis drugs and liver injury in tuberculosis patients during treatment

Analysis of 318 Cases with Anti-Tuberculosis Drug-Induced Liver Function Impairments

Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China

Investigation for prognosis of hospitalized patients with pulmonary tuberculosis and analysis for related factors

Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury.

Research of anti-tuberculosis drugs' hepatotoxicity

[Systematic Review of Anti-Tuberculosis Drug Induced Adverse Reactions in China].

Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients.

[Liver Injury Associated with Treatment of Multidrug-Resistant Tuberculosis: a Systematic Review and Meta-Analysis].

Meta-analysis of Preventive Effects of Hepatoprotective on Liver Damage in Patients Undergoing Initial Treatment for Tuberculosis

Study on Hereditary Susceptibility Genetic Markers to Anti-Tuberculosis Drug Induced Liver Injury in Chinese Population

Risk Factors of Anti-Tuberculosis Drugs Induced Liver Injury and Its Impact on the Treatment Outcome of Patients Treated with First Line Anti-Tuberculosis Drugs: a Historic Retrospective Cohort Study

Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study

Association of ABCC Gene Polymorphism with Susceptibility to Antituberculosis Drug–Induced Hepatotoxicity in Western Han Patients with Tuberculosis

Risk factors analysis on anti-TB treatment outcomes of 757 primary pulmonary tuberculosis cases

Clinical Analysis of Antituberculosis Drug-Induced Hepatotoxicity in HIV/TB Patients